Accelrys develops and commercializes scientific businessintelligence software for the integration, mining, analysis, modelingand simulation, management and interactive reporting of scientificdata.

We are a NASDAQ-listed public company (ACCL) that combines financial stability and a strong market position.

Innovation Our450 employees offer a unique blend of industry knowledge and expertisein science, software development, and systems implementation.

We offerhigh-quality service around the globe.

Over 150 PhD scientists maintainour products and innovate to extend and apply them.

New science emergesvia our product development, post-doctoral, sabbatical, and consortiumprograms.

Our customers are the world's leading pharmaceutical, chemical,biotechnology, nanotechnology, academic, and government researchorganizations.

Accelryscombines experience and intellectual property developed duringtwenty-five years of serving research organizations with modeling andsimulation, bioinformatics, cheminformatics, and middleware technology.

Accelryswas founded in 2001, bringing together five specialist companies—Molecular Simulations Inc. (MSI), Synopsys Scientific Systems, OxfordMolecular, the Genetics Computer Group (GCG®), and Synomics Ltd.

In2004, Accelrys acquired SciTegic Inc. These companies, in turn, hadcombined a total of seventeen software companies over the previousdecade— many of them startups from leading academic institutes.

Accelrys thus encompasses a rich pedigree of scientific achievement.